AEYE Health is a digital health company focused on developing and deploying advanced AI-powered solutions for retinal imaging and diagnostics. Their primary mission is to make comprehensive eye exams and early detection of sight-threatening diseases, such as diabetic retinopathy, glaucoma, and macular degeneration, more accessible and affordable. By leveraging artificial intelligence, AEYE Health aims to empower healthcare providers with tools for efficient and accurate screening, particularly in primary care settings, thereby improving patient outcomes and reducing healthcare costs associated with preventable blindness.
Serves as the central hub for strategic leadership, research and development coordination, business operations, commercial strategy, and global market engagement.
Located in a prominent commercial district in Midtown Manhattan, offering modern office amenities and access to a rich ecosystem of tech, finance, and healthcare partners.
Characterized by a fast-paced, innovative, and collaborative environment. The culture is mission-driven, focusing on leveraging cutting-edge AI technology to solve critical healthcare challenges in ophthalmology and improve patient lives.
The New York City headquarters strategically positions AEYE Health at the crossroads of global finance, technology, and healthcare, facilitating access to top talent, investment opportunities, and key strategic partnerships.
AEYE Health aims to democratize eye screening globally. Operations are anchored by its New York headquarters (business, strategy, commercialization) and its Tel Aviv R&D center (technology development). The company targets international markets, particularly focusing on regions and healthcare systems where access to specialized ophthalmological care is limited. Their AI-powered solutions are designed for deployment in diverse healthcare settings worldwide, including primary care clinics, pharmacies, mobile screening units, and community health centers, to enable early and accessible detection of eye diseases across varied populations.
135 W 50th St
New York
NY
USA
Address: Specific R&D facility address in Tel Aviv not publicly listed, common for focused research operations.
Leverages Israel's renowned and dense talent pool in AI, computer vision, cybersecurity, and medical technology to drive innovation and robust product development for AEYE Health's global diagnostic solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AEYE Health' leadership includes:
AEYE Health has been backed by several prominent investors over the years, including:
During the last 12 months (approximately mid-2023 to mid-2024), AEYE Health has not made public announcements regarding major new hires or departures within its top executive C-suite team. The company's leadership team has remained stable, focusing on product development, regulatory approvals, and commercial expansion efforts.
Discover the tools AEYE Health uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AEYE Health likely utilizes standard professional email address formats common in the technology and healthcare industries. These formats typically combine employee names with the company domain. The most common patterns are [first_initial][last] or [first].[last].
[first_initial][last]@aeyehealth.com or [first].[last]@aeyehealth.com
Format
zdveyaharon@aeyehealth.com or zack.dveyaharon@aeyehealth.com
Example
75%
Success rate
GlobeNewswire • January 9, 2024
AEYE Health and Optomed Plc announced an exclusive agreement to commercialize AEYE Health's AI-powered diabetic retinopathy screening solution integrated with Optomed's Aurora IQ handheld fundus camera in the United States market....more
Business Wire • August 2, 2023
AEYE Health announced it received its second FDA 510(k) clearance for the AEYE-DS, its AI-powered diabetic retinopathy screening system. This clearance expands its compatibility to include the Topcon NW400 fundus camera, making it the first such solution cleared with two different portable camera models....more
PR Newswire • June 26, 2023
AEYE Health's AI-based screening technology for diabetic retinopathy was presented at the American Diabetes Association's (ADA) 83rd Scientific Sessions. The presentation highlighted the system's performance and its potential to significantly improve early detection rates of diabetic retinopathy in primary care and other non-specialist settings....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AEYE Health, are just a search away.